Implementation of the WHO Framework Convention on Tobacco Control in Tunisia: Progress and challenges

Harizi, Chahida; El-Awa, Fatimah; Ghedira, Habib; Audera-Lopez, Carmen; Fakhfakh, Radhouane

doi:10.18332/tpc/130476

Cited by 9 publications

(13 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Tunisia is a middle-income country (MIC), which belongs to the WHO-EMRO. It ratified the FCTC on 7 June 2010 14 . Almost 8% of Tunisian students were current cigarette users.…”

Section: Discussionmentioning

confidence: 99%

“…These results were the opposite of ours, which may be due to the early implementation of laws prohibiting tobacco products sales to the underage in the US since 1992 and the enforcement of existing restricting rules in Italy in 2013 19 . Thus, in Tunisia, we have not signed yet any law that restricts selling tobacco products to minors 14 . It is highly recommended that such a law is implemented since it has an important role in decreasing smoking prevalence among youth and denormalizing cigarette buying by adolescents 20 .…”

Section: Access To Cigarettes and Water Pipementioning

confidence: 99%

“…Then, decree n°2009-2611 was adopted defining smoking areas' plans 28 . However, violation rate of these laws is still so high in Tunisia since the majority of smokers have continued to smoke in smoke-free places 14 .…”

Section: Exposure To Shsmentioning

confidence: 99%

See 2 more Smart Citations

Linking Global Youth Tobacco Survey (GYTS) data to the WHO Framework Convention on Tobacco Control (FCTC): The case for Tunisia

Ayedi¹,

Harizi²,

Skhiri³

et al. 2022

Tob. Induc. Dis.

Self Cite

View full text Add to dashboard Cite

INTRODUCTION The World Health Organization (WHO) had launched the Framework convention on Tobacco Control (FCTC) in 2003 in order to curve the epidemic of tobacco use worldwide. Since most smokers begin to smoke before the age of 18 years, Global Youth Tobacco Survey (GYTS) has been developed in order to monitor tobacco smoking among adolescents. Our aim was to assess smoking among Tunisian youth using GYTS 2017 data. METHODS GYTS is cross-sectional, two cluster school-based survey to produce a representative sample of students aged 13-15 years. It was conducted in 2017 in 67 secondary schools in Tunisia. The investigation tool was an anonymously answered questionnaire, which contained core questions about six majors tobacco related topics. RESULTS Lifetime cigarettes and waterpipe prevalence were 7.8% (14.4% of boys, 1.6% of girls, p<0.001) and 7.2% (13% of boys, 2.8% of girls, p<0.001), respectively. Among cigarette smokers, 62.5% were able to buy their own cigarettes. Overall, 23.5% of cigarette smokers and 41.5% of waterpipe smokers were not able to buy their products because of their age. Sixty percent of smokers wanted to quit and 56.4% had already tried to stop. Half of the respondents were exposed to SHS in their homes and 62.1% in indoor public places. CONCLUSIONS In Tunisia, tobacco prevalence among youth is high. Youth have free access to tobacco products and smoke-free regulations are only partially respected.

show abstract

“…Tunisia is a middle-income country (MIC), which belongs to the WHO-EMRO. It ratified the FCTC on 7 June 2010 14 . Almost 8% of Tunisian students were current cigarette users.…”

Section: Discussionmentioning

confidence: 99%

Section: Access To Cigarettes and Water Pipementioning

confidence: 99%

See 1 more Smart Citation

Linking Global Youth Tobacco Survey (GYTS) data to the WHO Framework Convention on Tobacco Control (FCTC): The case for Tunisia

Ayedi¹,

Harizi²,

Skhiri³

et al. 2022

Tob. Induc. Dis.

Self Cite

View full text Add to dashboard Cite

show abstract

“…Dans la littérature, c'est de loin la plus fréquente des polyconsommations [4]. Avec une population tabagique de 35%, la Tunisie est le premier consommateur arabe de tabac [5]. La consommation abusive d'alcool est à l'origine d'environ 2,5 millions de décès par an dans le monde.…”

Section: Discussionunclassified

The general practitioner in charge of addictive behavior: An exploratory study in Monastir city, Tunisia.

2021

JMR

View full text Add to dashboard Cite

Background Recent reports confirmed that more than 22% of adult world population are suffering from addiction. Tobacco and alcohol use remain the most prevalent addictive behaviors reported in Tunisia. The management of addiction is a multidisciplinary team concept. This entity may be underdiagnosed due to perception default at the first line of management. The aim of this study was to identify the limiting factors for addictive behavior approach in general practitioner (GP) clinic. Methods A cross-sectional study involved 84 GPs in the city of Monastir, Tunisia. Self‐ reported questionnaire was designed to survey the prevalence of patients with detectable addictive behavior among the outpatient GP clinic visitors. Results The participation rate was 93.3% (84/90). The prevalence of addictive behaviors was variable (38-59.5%). Tobacco use was the most common addiction (91.7%). More than seventy percent of questioned GPs were regularly consulting patients with known addictive behavior. The diagnosis was incidental in 7% of cases. Sixty percent of patients had predisposing factors for addiction. Diagnostic with screening difficulties for addictive behavior were independently related to doctor's age >40 (OR = 6.51; p = 0.005), exercise in private clinic (OR= 6.46; p=0.004). Thirty-three percent of GPs were more involved in addiction monitoring. The use of assessment scales was noted in 15%. Young physician age (OR=5.20; p=0.002) and the absence postgraduate diploma in addictology (OR=9.66; p=0.01) were significantly associated addiction management avoidance. Conclusion This study aimed to assess of the attitude of GP in Monastir city regarding the addictive behaviors of their patients. The diagnosis and the management of addiction is not standardized for these health practitioners and this will not contribute to the battle against this social entity. Key words Addictive behavior; general practitioner; perception ; exploration.

show abstract

“…The health problems caused by smoking have become an important consideration for public health. According to a World Health Organization (WHO) report, smoking is a significant factor leading to cardiovascular and respiratory diseases and more than 20 different types or subtypes of cancer [1,2]. More than eight million people die from tobacco use each year, and most of these deaths occur in low-and middle-income countries [3].…”

Section: Introductionmentioning

confidence: 99%

The Effects of Pharmacological Interventions on Smoking Cessation in People with Alcohol Dependence: A Systematic Review and Meta-analysis of Nine Randomized Controlled Trials

Guo

et al. 2021

Preprint

View full text Add to dashboard Cite

Background Pharmacotherapies are widely used for smoking cessation. However, their effect on smoking cessation for people with alcohol dependence remains unclear. Objective This study aimed to explore the effects of pharmacotherapies on smoking cessation for people with alcohol dependence. Methods Five electronic databases were searched in January 2021 for randomized controlled trials (RCTs) reporting the use of pharmacotherapies to promote smoking cessation in people with alcohol dependence. The risk of bias was assessed using the Cochrane tool. RevMan version 5.3 was used to perform meta-analyses of the changes in smoking behavior, and the GRADE approach was used to assess the certainty of the evidence. Results Nine RCTs involving 908 smokers with alcohol dependence were identified. Eight RCTs were published in the United States, and one was from Canada. The risk of bias was rated as low in three studies and unclear in the remaining six. The results of the meta-analysis showed that, compared with the placebo group, Varenicline had a significant effect on short-term smoking cessation (three RCTs, OR = 6.27, 95% CI: [2.49, 15.78], p < 0.05, very low certainty). Naltrexone had no significant effect on smoking cessation in short-term or long-term observations (three RCTs, OR = 0.99, 95% CI: [0.54, 1.81], p = 0.97, moderate certainty), and Topiramate had no significant effect (two RCTs, OR = 1.56, 95% CI: [0.67, 3.46], p > 0.05, low certainty). Only one trial reported that Bupropion had no effect on smoking cessation. Conclusion Varenicline may have a positive effect on smoking cessation in people with alcohol dependence. However, Naltrexone, Topiramate, and Bupropion seem to have no clear effect on increasing smoking abstinence among drinkers. The small number of studies and the low certainty of evidence indicate that caution is required in interpreting the results.

show abstract

Implementation of the WHO Framework Convention on Tobacco Control in Tunisia: Progress and challenges

Cited by 9 publications

References 17 publications

Linking Global Youth Tobacco Survey (GYTS) data to the WHO Framework Convention on Tobacco Control (FCTC): The case for Tunisia

Linking Global Youth Tobacco Survey (GYTS) data to the WHO Framework Convention on Tobacco Control (FCTC): The case for Tunisia

The general practitioner in charge of addictive behavior: An exploratory study in Monastir city, Tunisia.

The Effects of Pharmacological Interventions on Smoking Cessation in People with Alcohol Dependence: A Systematic Review and Meta-analysis of Nine Randomized Controlled Trials

Contact Info

Product

Resources

About